Research Article
Lipoprotein(a) Is the Best Single Marker in Assessing Unstable Angina Pectoris
Table 2
Demographic characteristics, standard and inflammatory markers in statin-treated and non-statin-treated IHD patients.
| | SAP(+) | SAP(−) | USAP(+) | USAP(−) | STEMI(+) | STEMI(−) | Controls |
| | Male/female (N) | 34/17 | 18/13 | 35/12 | 15/18 | 37/18 | 35/16 | 30/19 | | Age | 61.4 ± 6.8 | 59.8 ± 8.4 | 63.2 ± 7.5 | 62.6 ± 6.4 | 63.2 ± 9.8 | 62.9 ± 11.4 | | | Glucose (mmol/L) | 5.72 ± 1.56 | 5.95 ± 1.73 | 6.41 ± 0.48 | 5.98 ± 2.29 | 6.31 ± 2.17 | 6.99 ± 3.17 | 5.19 ± 0.59 | | Creatinine (μmol/L) | 88.8 ± 15.9 | 97.2 ± 31.2 | 111.4 ± 38.9 | 117.2 ± 109.4 | 88.4 ± 21.8 | 103.0 ± 34.2 | 85.1 ± 13.9 | | Troponin I (ng/mL) | 0.00 ± 0.01 | 0.08 ± 0.32 | 0.0 (0.0–21.4) | 0.0 (0.0–19.5) | 12.8 (0.37–227.8) | 9.8 (0.001–22.8) | 0 | | hsCRP (g/L) | 2.7 (0.4–19.4) | 3.1 (0.74–84.4) | 6.2 (0.6–78.4) | 4.7 (0.4–122.9) | 12.8 (2.1–186.3) | 20.9 (0.6–270.3) | 1.3 (0.1–16.5) | | Fibrinogen (g/L) | 3.9 (2.1–7.0) | 5.1 (2.6–5.6) | 4.9 (2.0–7.6) | 4.8 (3.7–8.5) | 4.6 (0.3–7.8) | 5.3 (2.5–11.4) | 3.7 (2.1–7.3) | | Neopterin (nmol/L) | 14.5 (3.0–57.0) | 17 (8.0–55.0) | 14.3 (1.0–105.0) | 14.5 (6.0–19.3) | 12.8 (1.0–52.0) | 13.2 (5.0–32.0) | 13.4 (1.0–19.6) | | iNOS (U/L) | 2.5 (0.5–4.7) | 1.4 (0.5–2.2) | 2.3 (0.9–5.7) | 3.0 (1.7–6.0) | 2.8 (0.9–4.7) | 3.2 (1.4–6.2) | 2.2 (0.6–9.3) | | / (μmol/L) | 96.1 (34.9–194.9) | 93.0 (67.4–197.4) | 124.6 (78.6–196.6) | 127.4 (51.8–154.3) | 97.5 (61.5–243.0) | 105.5 (75.0–224.9) | 97 (57–229) | | TNF-α (pg/mL) | 12.7 (10.8–15.2) | 13. (13.1–13.9) | 13.1 (12.0–18.9) | 13.2 (12.0–18.3) | 15.1 (12.1–18.3) | 13.6 (10.9–14.5) | 13.1 (11.2–19.7) |
|
|
The results are presented as for parametric, and median (min–max) for nonparametric values.
|
